2025 annual financial data
Eupraxia Pharmaceuticals 2025 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -53,659,677 USD and net income was -53,858,075 USD.
Operating cash flow was -29,028,363 USD.
Get free Eupraxia Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -53,659,677 USD
- Net income
- -53,858,075 USD
- Operating cash flow
- -29,028,363 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Eupraxia Pharmaceuticals financial years